Pediatric ingestion of lamotrigine.
A 3-year-old female presented to the emergency department after ingesting forty-six 25-mg tablets of lamotrigine that resulted in sedation, rash, and transient elevation of liver function tests. Her initial physical examination was significant for marked somnolence and a lacy reticular blanching rash. Laboratory studies were all within normal limits except for mildly elevated liver function tests. Initial plasma lamotrigine level was found to be elevated above adult therapeutic levels (25.3 microg/mL). Treatment consisted of gastric lavage followed by activated charcoal. The patient was subsequently observed in the pediatric intensive care unit where symptoms and laboratory abnormalities promptly resolved, and she was discharged 24 hours later without further complication. This case report describes the largest single ingestion of lamotrigine ever reported in a pediatric patient. The patient exhibited significant somnolence, rash, and liver function test abnormalities with only a slight elevation of serum level of lamotrigine above adult therapeutic levels. More research is required to investigate the toxic profile of lamotrigine in pediatric patients.
Zidd
Andrea G
AG
Department of Emergency Medicine at The Brody School of Medicine at East Carolina University, Greenville, North Carolina 27858, USA.
Hack
Jason B
JB
D000927:Anticonvulsants / Q000097:blood / Q000506:poisoning*; D003244:Consciousness Disorders / Q000139:chemically induced*; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007223:Infant; D000077213:Lamotrigine; D008099:Liver / Q000187:drug effects; D014227:Triazines / Q000097:blood / Q000506:poisoning*
D000927:Anticonvulsants; D014227:Triazines; D000077213:Lamotrigine